These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32502586)
1. Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review. Stewart CR; Algu L; Kamran R; Leveille CF; Abid K; Rae C; Lipner SR J Am Acad Dermatol; 2021 Nov; 85(5):1227-1239. PubMed ID: 32502586 [TBL] [Abstract][Full Text] [Related]
2. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment. Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
4. Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure. Gupta AK; Daigle D; Paquet M J Am Podiatr Med Assoc; 2015 Jul; 105(4):357-66. PubMed ID: 25032982 [TBL] [Abstract][Full Text] [Related]
5. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Jaiswal A; Sharma RP; Garg AP Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857 [TBL] [Abstract][Full Text] [Related]
11. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. Baran R; Hay RJ; Garduno JI J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426 [TBL] [Abstract][Full Text] [Related]
12. Antifungal Drug Use for Onychomycosis. Thomas J; Peterson GM; Christenson JK; Kosari S; Baby KE Am J Ther; 2019; 26(3):e388-e396. PubMed ID: 31082864 [TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis. Schaller M; Sigurgeirsson B; Sarkany M Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059 [TBL] [Abstract][Full Text] [Related]
15. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
16. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective. Elsayed MM J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439 [TBL] [Abstract][Full Text] [Related]
18. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis. Gupta AK; Foley KA; Mays RR; Shear NH; Piguet V Br J Dermatol; 2020 Feb; 182(2):287-299. PubMed ID: 31120134 [TBL] [Abstract][Full Text] [Related]
19. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails. Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707 [TBL] [Abstract][Full Text] [Related]